Hygromycin B solutionAn antibiotic often used for selection of cells transfected with E. coli hygromycin resistance gene.

Hygromycin B solution (CAS 31282-04-9)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 70ms
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Synonym Hygrovetine; D-streptamine
Anwendungen An antibiotic often used for selection of cells transfected with E. coli hygromycin resistance gene.
CAS Nummer: 31282-04-9
Reinheit: >90%
Molekulargewicht: 527.52
Summenformel: C20H37N3O13
Supplemental Information: This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
* Schauen Sie auf das Analysezertifikat (CoA), um die genauen Daten (inkl. Wassergehalt) Ihrer Produktionscharge (Lot) zu sehen.
Bewerten Sie dieses Produkt und erhalten Sie 15 CruzCredits

Hygromycin B is an aminoglycoside antibiotic substance naturally produced by Streptomyces hygroscopicus, which also shows anthelmintic activity. Hygromycin B has been shown to effectively inhibit translocation of mRNA and tRNAs on the ribosome in both bacteria and eukaryotes and also has a subtle effect on decoding fidelity as it slightly increases aminoacyl tRNA (A-site tRNA) affinity. Suitable for the selection of cells transfected with Escherichia coli hygromycin resistance gene (hyg or hph), as well as for the maintenance of the Hygromycin phenotype of resistant cells. Consistent with its more specific effect on translocation, hygromycin B exhibits monophasic inhibition of polypeptide synthesis, suggesting that it binds to a single site on the ribosome.


1. González, A., et al. 1978. Biochim. Biophys. Acta. 521: 459-469. PMID: 367435
2. Rao, R.N., et al. 1983. Antimicrob. Agents Chemother. 24: 689-695. PMID: 6318654
3. Cullen, D., et al. 1987. Gene. 57: 21-26. PMID: 3322945
4. Perlin, D.S., et al. 1988. J. Biol. Chem. 263: 18118-18122. PMID: 3056938
5. Kronstad, J.W., et al. 1989. Gene. 79: 97-106. PMID: 2673937
6. Perlin, D.S., et al. 1989. J. Biol. Chem. 264: 21857-21864. PMID: 2532214
7. Egelhoff, T.T., et al. 1989. Mol. Cell. Biol. 9: 1965-1968. PMID: 2546056
8. Salauze, D., et al. 1990. Antimicrob. Agents Chemother. 34: 1915-1920. PMID: 1963287
9. Bilang, R., et al. 1991. Gene. 100: 247-250. PMID: 1647356
10. Dean, N., 1995. Proc. Natl. Acad. Sci. U.S.A. 92: 1287-1291. PMID: 7877969

Gebrauch :
• This product is provided as 20 mL of a sterile filtered solution in PBS.

• Appearance: Solution color can vary from light yellow to a dark brown or caramel color. Concentrated Hygromycin solution tends to have a darker appearance.

• The working concentration for the purpose of selection varies with cell type, media, growth conditions and cell metabolic rate. A titration experiment for each cell type should be performed to determine the amount of Hygromycin B needed to kill non-transfected cells.

• Recommended concentrations for the selection of resistant cells is 25-1000 μg/ml. Commonly used concentrations for selection are 200 μg/ml for mammalian cells, 20-200 μg/ml for plant cells & bacteria cells and 200-1000 μg/ml for fungi. Your optimum concentration should be tested experimentally.

• Control cells should die within 5-7 days after addition of the antibiotic allowing colonies of resistant cells to form by 10–14 days.
Formulierung :
50 mg/ml in PBS
Erscheinung :
Aggregatzustand :
Erhaltene Form :
Streptomyces hygroscopicus
Löslichkeit :
Soluble in water, methanol, buffer solution, and ethanol.
Store at 4° C
Ausschließlich für Forschungszwecke. Nicht Geeignet für Verwendung in Diagnostik oder Therapie.
PubChem CID :
Merck Index :
14: 4852
MDL-Nummer :
EC-Nummer :

SDS (MSDS) herunterladen


Um PDF-Dokumente zu Drucken oder zu Bearbeiten
benötigen Sie Adobe Acrobat Reader

Hygromycin B solution  Publikationen

Lesen Sie wie andere Anwender Hygromycin B solution eingesetzt haben. Klicken Sie auf den jeweiligen Eintrag um den entsprechenden PubMed-Abstract abzurufen .

Produktreferenz 1 bis 10 von 22 insgesamt

PMID: # 30838870  Wu, M.|Feng, Y.|Ye, GX.|Han, YC.|Wang, SS.|Ni, HF.|Wang, FM.|Gao, M.|Lv, LL.|Liu, BC.| et al. 2019. Am. J. Physiol. Renal Physiol. 316: F1006-F1015.

PMID: # 30881116  Chiang, KC.|Huang, ST.|Wu, RC.|Huang, SC.|Yeh, TS.|Chen, MH.|Hsu, JT.|Chen, LW.|Kuo, SF.|Chueh, HY.|Juang, HH.|Hung, SI.|Yeh, CN.|Pang, JS.| et al. 2019. Cancer Manag Res. 11: 1893-1905.

PMID: # 30034634  Barone, G.|Arora, A.|Ganesh, A.|Abdel-Fatah, T.|Moseley, P.|Ali, R.|Chan, SY.|Savva, C.|Schiavone, K.|Carmell, N.|Myers, KN.|Rakha, EA.|Madhusudan, S.|Collis, SJ.| et al. 2018. Oncotarget. 9: 29508-29524.

PMID: # 28870912  Pan, PJ. et al. 2017. Anticancer Res. 37: 4911-4918.

PMID: # 25271153  Kannike, K. et al. 2014. J. Biol. Chem. 289: 32845-57.

PMID: # 24606125  Eigler, T. et al. 2014. Mol. Endocrinol. 28: 554-64.

PMID: # 19468300  Wolfe, BA. et al. 2009. PLoS Biol. 7: -.

PMID: # 17362967  Laurentino, EC. et al. 2007. Int. J. Parasitol. 37: 735-742.

PMID: # 17995645  Lu, Y. et al. 2007. J. Food Sci. 72: M228-M232.

PMID: # 17470460  Kaimori, JY. et al. 2007. Hum. Mol. Genet. 16: 942-56.

Produktreferenz 1 bis 10 von 22 insgesamt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 67ms
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 3ms
  • bvseo-msg: The resource to the URL or file is currently unavailable.;

Santa Cruz Biotechnology, Inc. ist weltweit führend in der Entwicklung von Produkten für den biomedizinischen Forschungsmarkt. Rufen Sie uns an, gebührenfrei unter 00800 4573 8000. .
Copyright © 2007-2019, Santa Cruz Biotechnology, Inc. Alle Rechte vorbehalten. "Santa Cruz Biotechnology", das Santa Cruz Biotechnology, Inc. Logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", das San Juan Ranch Logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz" und "EZ Touch" sind eingetragene Warenzeichen der Santa Cruz Biotechnology, Inc. Alle genannte Warenzeichen sind Eigentum der jeweiligen Inhaber. Alle Rechte vorbehalten.